iCardio.ai’s AI suite (pending FDA 510(k) clearance) includes instant automated interpretation of dozens of measurements of the heart, valvular disease detection, and image quality assessment. With this partnership, iCardio.ai will be compatible with Butterfly’s leading imaging platform.

The acquisition enhances patient care and extends CLS Health's geographical reach in the Houston area.

Study demonstrates efficacy of StatSeal® Advanced Plus Disc use for groin closure following atrial fibrillation ablation procedures to treat patients with irregular heartbeats.

The American Heart Association certification recognizes commitment to following the
latest evidence-based treatment guidelines

Modern Heart and Vascular Institute is proud to offer an intensive cardiac rehabilitation program designed to help patients get back to their normal lives after being diagnosed with cardiovascular disease.

Receives eighth FDA clearance, releases its next-generation Cardio AI application

Virtual-First Cardiology Company, Heartbeat Health, Achieves SOC 2® Security Control Compliance Certification, Reinforcing Its Commitment to Healthcare Data Security & Privacy.

New look and logo to position Radcliffe as a multimedia knowledge network and global market leader for the cardiovascular community.

New heart scan technology for the emergency room

Exclusive North American Agreement

The NIVA|HF investigational algorithm uses proprietary venous waveform technology from VoluMetrix to assess otherwise hard-to-obtain cardiovascular metrics. According to study authors, 'This non-invasive measurement has potential for … prevention of hospital admission in heart failure patients.'

Accumed Radial is pleased to announce renowned entrepreneur and venture capitalist William (Bill) N. Starling has become an investor and joined the Accumed Radial Board of Directors.

JAPSC now open to submissions

Interventional Cardiology Review (ICR) journal names Dr Peter O'Kane as ICR's new Editor-in-Chief. Dr O'Kane's term begins July 26, 2021.

Jason Powell joins as Non-Executive Director

Focused on preventing surgeries and use of medications, Modern Heart and Vascular Institute has an educational and holistic approach to heart and vascular care.

NIVA|HF is an investigational device designed to monitor the venous waveform, a novel physiologic signal, in heart failure patients. As a Breakthrough Device, NIVA|HF will receive pre-market developmental assistance and prioritized regulatory review from FDA. NIVA|HF is the first application of VoluMetrix's proprietary venous waveform technology.

APAC clinical trial market is projected to attain a CAGR of 8.1% till 2027 due to emergence of severe diseases, huge patient population, increasing clinical trials and R&D.

Esteemed Board-Certified Cardiologist Michael Siropaides, MD joins Modern Heart and Vascular Institute, bringing 30 years of excellent bedside cardiovascular skills and experience.

US Cardiology Review (USC) journal names Dr Bill Gogas, MD, PhD, FACC as USC's new Editor-in-Chief. Dr Gogas' term begins December 1st, 2020.

Modern Heart and Vascular Institute is expanding to Cleveland, Texas. They will be opening a full-time clinic at 212 N College Ave. Suite B, Cleveland, TX 77327.

Noted Tampa Bay Cardiologist, Dr. Tamboli, Joins a new Practice

Modern Heart and Vascular Institute is now seeing patients in Katy, Texas. The technologically advanced practice can diagnose and prevent numerous cardiovascular diseases and conditions at the earliest stages by utilizing the very best imaging and non-imaging modalities.

Heart disease is the number one cause of death in our country. New technology at Modern Heart and Vascular allows early diagnosis of blockages with a 1-2 seconds scan in the comfort of a state-of-the-art office.

First AI-assisted handheld ultrasound tool to increase diagnostic confidence at the bedside, just in time for COVID-19

350+ leaders of hospitals, health systems and cardiology departments weigh in on top trends in heart care and where they wish to take it

The first AI-assisted hand-held tool to increase diagnostic confidence at the bedside

North America diagnostic ultrasound market accounted for more than $1.5 billion revenue in 2018 and is expected to grow exponentially over forecast timeframe as high adoption of unhealthy diet, hypertension and obesity has escalated prevalence of chronic diseases in the region.

The newly built facility features amenities to enhance the patient experience

Company also announces appointments to Scientific Advisory Board

Michael C. Turner, M.D., of Cardiovascular Specialists of Southwest Louisiana to speak at the International Congress on Innovations in Coronary Artery Disease in Venice, Italy, on breakthroughs in Cardiac CT Triage - October 15, 16 and 17, 2017

Announced by ingenious targeting laboratory

Gladstone scientists show that a cancer drug is effective in treating common causes of heart failure

MASTER-DAPT kicks-off with the enrolment of its first patient by Treant Zorggroep, Scheper Hospital

Listed as Rising Star 2017

​Global study involving 4,300 patients from 34 countries announced at EuroPCR

New Local Doctor First In Kansas And Kc Region Performed First Venaseal Procedure